Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Delux Chemical Industries

Pharmaceutical manufacturer · Karachi · Pakistan

Karachi pharmaceutical manufacturer represented in DRAP regulatory records.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check9 Aug 2026Latest source-check date across this published portfolio
Latest effective price date1 Jul 2025Newest effective date among published current price records
Corporate profile evidence1 sourceCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Corporate source details checked
16 Aug 2026
Corporate profile completeness
38%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000033 Delux Chemical Industries. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000033 44 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Exact site not yet sourced

No exact premises location is published without a defensible source.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx44public portfolio records represented
REG35unique registrations represented
IDX44indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR44current validated price records
G20generic molecules in indexed catalogue
DF6dosage-form groups
TA7therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage100%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage95%
priced packs safely normalized per unit
Comparable-market coverage84%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixDelux Chemical IndustriesShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/delux-chemical-industriesGenerated 23 Sep 2026Anti-infectives22 · 50%Pain & musculoskeletal11 · 25%CNS & mental health4 · 9%Vitamins, minerals & nutrition2 · 5%Gastrointestinal & hepatology2 · 5%Respiratory & allergy2 · 5%Hematology & thrombosis1 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioDelux Chemical IndustriesDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/delux-chemical-industriesGenerated 23 Sep 202644presentationsTablet22 · 50%Suspension10 · 23%Cream5 · 11%Syrup4 · 9%Capsule2 · 5%Drops1 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionDelux Chemical IndustriesCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/delux-chemical-industriesGenerated 23 Sep 202637comparable productsBelow peer median21 · 57%Near peer median7 · 19%Above peer median9 · 24%Company median price position-9.1%Lowest-price equivalents4Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsDelux Chemical IndustriesCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/delux-chemical-industriesGenerated 23 Sep 2026Nabiqasim Industries (Pvt) Ltd.,13 shared65% overlapSemos Pharmaceuticals PVT LTD13 shared65% overlapWerrick Pharmaceuticals12 shared60% overlapZafa Pharmaceutical Laboratories (P…12 shared60% overlapMedisure Laboratories Pakistan Pvt …12 shared60% overlapAtco Laboratories Limited11 shared55% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives22 products · 50%
Pain & musculoskeletal11 products · 25%
CNS & mental health4 products · 9%
Vitamins, minerals & nutrition2 products · 5%
Gastrointestinal & hepatology2 products · 5%
Respiratory & allergy2 products · 5%
Hematology & thrombosis1 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Analgesics / NSAIDs11 products · 25%
Antimalarials5 products · 11%
Antipsychotics4 products · 9%
Antifungals4 products · 9%
Antiparasitic medicines3 products · 7%
Third-generation cephalosporins3 products · 7%
Nitroimidazole anti-infectives3 products · 7%
Other systemic antibacterials2 products · 5%
Formulation footprint

Dosage forms

Tablet22 products
Suspension10 products
Cream5 products
Syrup4 products
Capsule2 products
Drops1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 DeepolParacetamol 5presentations 120 mg/5 mL, 500 mg · Suspension, Tablet #2 DecidoneRisperidone 4presentations 1 mg, 2 mg, 3 mg, 4 mg · Tablet #3 DeloquinChloroquine 4presentations 250 mg, 81 mg/5 mL · Tablet, Syrup #4 MimluxCefixime 3presentations 100 mg/5 mL, 200 mg/5 mL, 400 mg · Suspension, Capsule #5 Panil-SIbuprofen 3presentations 100 mg/5 mL · Suspension #6 RosacedMetronidazole (Benzoate) 3presentations 321.6 mg, 321.6 mg/5 mL, 400 mg · Tablet, Suspension
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2157% of comparable products
Near market median7within ±5% of median
Above market median924% of comparable products
Lowest-price equivalents4ties included
Company median price position -9.1% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Deerin 300 mgAcetylsalicylic acid (Aspirin) · Tablet · 1000's PKR 0.16/tablet-95.1% vs market median Delosol 40 mgLevamisole · Tablet · 3x10's Blister PKR 5.87/tablet-61.4% vs market median Deefol 5 mgFolic acid · Tablet · 1000's PKR 0.31/tablet-61.0% vs market median Decidone 3 mgRisperidone · Tablet · 10's Blister PKR 26.40/tablet-54.7% vs market median Decidone 2 mgRisperidone · Tablet · 10's Blister PKR 22.00/tablet-40.6% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 13shared generics Semos Pharmaceuticals PVT LTD104 products · 45 generics 13shared generics Werrick Pharmaceuticals249 products · 82 generics 12shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 12shared generics Medisure Laboratories Pakistan Pvt Ltd120 products · 56 generics 12shared generics Atco Laboratories Limited278 products · 94 generics 11shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers35Distinct registrations among indexed, published, presentation-validated products only
Verified price observations44
Products with a verified price44
Products with multiple price observations0
Source records with multiple versions44
Latest portfolio source check9 Aug 2026
Latest effective price date1 Jul 2025
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

35 unique registration(s) · 44 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Alba-200 Albendazole 200 mg/5 mL Suspension 10ml Bottle 039485 PKR 41.10 PKR 4.11/mL No comparator
Decidone Risperidone 1 mg Tablet 10's Blister 058156 PKR 140.78 PKR 14.08/tablet 40% below median
Decidone Risperidone 2 mg Tablet 10's Blister 058157 PKR 219.96 PKR 22.00/tablet 41% below median
Decidone Risperidone 3 mg Tablet 10's Blister 058158 PKR 263.95 PKR 26.40/tablet 55% below median
Decidone Risperidone 4 mg Tablet 10's Blister 058159 PKR 527.90 PKR 52.79/tablet 28% below median
Deconazole Miconazole 20 mg/g Cream 10gm Tube 042117 PKR 79.18 PKR 7.92/g 19% above median
Deconazole Miconazole 20 mg/g Cream 20gm Tube 042117 PKR 158.37 PKR 7.92/g 19% above median
Dectron Trimethoprim 40 mg/5 mL Suspension 50ml Bottle 033678 PKR 38.90 PKR 0.78/mL No comparator
Dectron DS Sulfamethoxazole 160 mg Tablet 100's Blister 061198 PKR 923.71 PKR 9.24/tablet 113% above median
Deefol Folic acid 5 mg Tablet 100's 013945 PKR 80.04 PKR 0.80/tablet Near median
Deefol Folic acid 5 mg Tablet 1000's 013945 PKR 314.11 PKR 0.31/tablet 61% below median
Deepol Paracetamol 500 mg Tablet 500's 013946 PKR 1,619.26 PKR 3.24/tablet 11% below median
Deepol Paracetamol 500 mg Tablet 200's 013946 PKR 660.92 PKR 3.30/tablet 9% below median
Deepol Paracetamol 500 mg Tablet 1000's 013946 PKR 3,213.95 PKR 3.21/tablet 12% below median
Deepol Paracetamol 120 mg/5 mL Suspension 450ml 013949 PKR 386.68 PKR 0.86/mL 18% below median
Deepol Paracetamol 120 mg/5 mL Suspension 60ml 013949 PKR 62.91 PKR 1.05/mL Near median
Deerin Acetylsalicylic acid (Aspirin) 300 mg Tablet 1000's 013948 PKR 162.64 PKR 0.16/tablet 95% below median
Deloquin Chloroquine 250 mg Tablet 200's 025659 PKR 610.45 PKR 3.05/tablet 98% above median
Deloquin Chloroquine 250 mg Tablet 1000's 025659 PKR 1,374.03 PKR 1.37/tablet 12% below median
Deloquin Chloroquine 81 mg/5 mL Syrup 450ml Bottle 030997 PKR 258.96 PKR 0.58/mL 8% below median
Deloquin Chloroquine 81 mg/5 mL Syrup 60ml Bottle 030997 PKR 37.53 PKR 0.63/mL 9% above median
Delosol Levamisole 40 mg Tablet 3x10's Blister 042388 PKR 175.97 PKR 5.87/tablet 61% below median
Delser Omeprazole 20 mg Capsule 7x2's Bilster 025853 PKR 193.56 — No comparator
Deotrix Permethrin 50 mg/g Cream 30gm Tube 037764 PKR 116.98 PKR 3.90/g 25% above median
Kidi-Para Paracetamol 80 mg/0.8 mL Drops 15ml Dropper 061909 PKR 35.19 — No comparator
Lactulac Lactulose 6.7 g/100 mL Syrup 120ml Bottle 030342 PKR 249.88 PKR 2.08/mL No comparator
Loratine Loratadine 10 mg Tablet 10's Blister 027911 PKR 191.81 PKR 19.18/tablet 34% above median
Loratine Loratadine 5 mg/5 mL Syrup 30ml Bottle 027912 PKR 56.31 PKR 1.88/mL 11% above median
Megacip Ciprofloxacin 500 mg Tablet 10's 070524 PKR 378.32 PKR 37.83/tablet 12% below median
Megacip Ciprofloxacin 250 mg Tablet 10's 070525 PKR 228.75 PKR 22.88/tablet 10% below median
Mimlux Cefixime 100 mg/5 mL Dry suspension 30ml Bottle 058469 PKR 299.45 PKR 9.98/mL Near median
Mimlux Cefixime 200 mg/5 mL Dry suspension 30ml Bottle 058470 PKR 366.45 PKR 12.22/mL Near median
Mimlux Cefixime 400 mg Capsule 5's 058471 PKR 536.59 PKR 107.32/capsule Near median
Panil-4 Ibuprofen 400 mg Tablet 10's Blister 028179 PKR 34.48 PKR 3.45/tablet Near median
Panil-6 Ibuprofen 600 mg Tablet 10's Blister 028180 PKR 64.23 PKR 6.42/tablet Near median
Panil-S Ibuprofen 100 mg/5 mL Suspension 120ml Bottle 028177 PKR 129.12 PKR 1.08/mL 14% above median
Panil-S Ibuprofen 100 mg/5 mL Suspension 60ml Bottle 028177 PKR 50.38 PKR 0.84/mL 11% below median
Panil-S Ibuprofen 100 mg/5 mL Suspension 90ml Bottle 028177 PKR 75.59 PKR 0.84/mL 11% below median
Prozoquine Amodiaquine 150 mg Tablet 60x10's Blister 033675 PKR 1,667.04 PKR 2.78/tablet 23% below median
Rosaced Metronidazole (Benzoate) 321.6 mg Tablet 10x10's Blister 030343 PKR 187.65 PKR 1.88/tablet No comparator
Rosaced Metronidazole (Benzoate) 321.6 mg/5 mL Suspension 60ml Bottle 030344 PKR 56.31 PKR 0.94/mL No comparator
Rosaced Metronidazole (Benzoate) 400 mg Tablet 100's Blister 061717 PKR 281.48 PKR 2.81/tablet 9% below median
Vegizole -V Clotrimazole 10 % Cream 5gm Tube 033301 PKR 126.56 PKR 25.31/g 34% below median
Vegizole W/W Clotrimazole 1 % Cream 10gm Tube 028174 PKR 52.79 PKR 5.28/g 17% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Delux Chemical Industries — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/delux-chemical-industries/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.